Back to Search
Start Over
Weighing the Evidence of Efficacy of Oral PrEP for HIV Prevention in Women in Southern Africa.
- Source :
-
AIDS research and human retroviruses [AIDS Res Hum Retroviruses] 2018 Aug; Vol. 34 (8), pp. 645-656. Date of Electronic Publication: 2018 Jun 19. - Publication Year :
- 2018
-
Abstract
- As oral tenofovir-based regimens for preexposure prophylaxis (PrEP) are adopted as standard of care for HIV prevention, their utilization in clinical trials among women in southern Africa will require an accurate estimate of oral PrEP efficacy in this population. This information is critical for women in choosing this prevention strategy, and in public health policy making. Estimates of the efficacy of oral PrEP regimens containing tenofovir have varied widely across trials that enrolled women, with some studies reporting high efficacy and others reporting no efficacy. Although poor adherence is strongly associated with lack of efficacy, other factors, such as mode of transmission (sexual vs. parenteral), predominant HIV subtype (C vs. non-C), intensity of exposure, and percentage of stable serodiscordant couples, may also contribute to the variation in efficacy estimates. In this article, we evaluate the evidence for PrEP efficacy in women and propose potential explanations for the observed differences in efficacy among studies. Our review emphasizes the need to continue to refine estimates of efficacy and effectiveness of tenofovir-based oral PrEP so as to best develop the next generation of HIV prevention tools, and to inform public policies directed toward HIV prevention.
Details
- Language :
- English
- ISSN :
- 1931-8405
- Volume :
- 34
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- AIDS research and human retroviruses
- Publication Type :
- Academic Journal
- Accession number :
- 29732896
- Full Text :
- https://doi.org/10.1089/AID.2018.0031